Article
Analysis of CYP2A contributions to metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in human peripheral lung microsomes.
Drug metabolism and disposition: the biological fate of chemicals - 1 Nov 2007
Brown Pamela J, Bedard Leanne L, Reid Ken R, Petsikas Dimitri, Massey Thomas E
Abstract excerpt
The objectives of this study were to determine the contributions of CYP2A13 and CYP2A6 to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) metabolism in human peripheral lung microsomes and to determine the influence of the genetic polymorphism, CYP2A13 Arg257Cys, on NNK metabolism. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), the keto-reduced metabolite of NNK, was the major metabolite produced,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
